The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Botulinum toxin in clinical practice
Open accessAbstract
Botulinum toxin, the most potent biological toxin, has become a powerful therapeutic tool for a growing number of clinical applications. This review draws attention to new findings about the mechanism of action of botulinum toxin and briefly reviews some of its most frequent uses, focusing on evidence based data. Double blind, placebo controlled studies, as well as open label clinical trials, provide evidence that, when appropriate targets and doses are selected, botulinum toxin temporarily ameliorates disorders associated with excessive muscle contraction or autonomic dysfunction. When injected not more often than every three months, the risk of blocking antibodies is slight. Long term experience with this agent suggests that it is an effective and safe treatment not only for approved indications but also for an increasing number of off-label indications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Botulinum Toxin as a Biological Weapon: Medical and Public Health Management
Arnon, S. S., Schechter, R., Inglesby, T. V., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., Fine, A. D., Hauer, J., Layton, M., et al. (2001) · JAMA · doi:10.1001/jama.285.8.1059 · Cited by 1,814
Neurotoxins Affecting Neuroexocytosis
Schiavo, G., Matteoli, M., & Montecucco, C. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.2.717 · Cited by 1,269
de Paiva, A., Meunier, F. A., Molgó, J., Aoki, K. R., & Dolly, J. O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3200 · Cited by 673
Brashear, A., Gordon, M. F., Elovic, E. P., Kassicieh, V. D., Marciniak, C. M., Do, M., Lee, C.-H., JENKINS, S. W., & Turkel, C. C. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011892 · Cited by 565
Intrasphincteric Botulinum Toxin for the Treatment of Achalasia
Pasricha, P. J., Ravich, W. J., Hendrix, T. R., Sostre, S., Jones, B., & Kalloo, A. N. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321203 · Cited by 556
Botulinum A toxin for cranial‐cervical dystonia: A double‐blind, placebo‐controlled study
Jankovic, J., & Orman, J. (1987) · Neurology · doi:10.1212/wnl.37.4.616 · Cited by 553
Self-citationJankovic, J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010032 · Cited by 447
Self-citationSafety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia
Brin, M. F., Lew, M. F., Adler, C. H., Comella, C. L., Factor, S. A., Jankovic, J., O’Brien, C., Murray, J. J., Wallace, J. D., Willmer–Hulme, A., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1431 · Cited by 437
Self-citationRecommendations for the use of botulinum toxin type A in the management of cerebral palsy
Graham, H. K., Aoki, K. R., Autti-Rämö, I., Boyd, R. N., Delgado, M. R., Gaebler-Spira, D. J., Gormley, M. E., Guyer, B. M., Heinen, F., Holton, A. F., et al. (2000) · Gait & Posture · doi:10.1016/s0966-6362(99)00054-5 · Cited by 399
Brisinda, G., Maria, G., Bentivoglio, A. R., Cassetta, E., Gui, D., & Albanese, A. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410201 · Cited by 379
Jankovic, J., Schwartz, K., & Donovan, D. T. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.8.633 · Cited by 353
Self-citationForan, P. G., Mohammed, N., Lisk, G. O., Nagwaney, S., Lawrence, G. W., Johnson, E., Smith, L., Aoki, K. R., & Dolly, J. O. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209821200 · Cited by 340
Bhakta, B. B. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.2.217 · Cited by 299
Botulinum toxin A and chronic low back pain: A randomized, double-blind study
Foster, L., Clapp, L., Erickson, M., & Jabbari, B. (2001) · Neurology · doi:10.1212/wnl.56.10.1290 · Cited by 297
Kessler, K. R., Skutta, M., & Benecke, R. (1999) · Journal of Neurology · doi:10.1007/s004150050345 · Cited by 276
Management of upper limb dysfunction in children with cerebral palsy: a systematic review
Boyd, R. N., Morris, M. E., & Graham, H. K. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00048.x · Cited by 267
Hyman, N. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.6.707 · Cited by 248
A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease
Ondo, W. G., Hunter, C., & Moore, W. (2004) · Neurology · doi:10.1212/01.wnl.0000101713.81253.4c · Cited by 239
Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J. (1996) · Movement Disorders · doi:10.1002/mds.870110306 · Cited by 235
Self-citationA randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor
Brin, M. F., Lyons, K. E., Doucette, J., Adler, C. H., Caviness, J. N., Comella, C. L., Dubinsky, R. M., Friedman, J. H., Manyam, B. V., Matsumoto, J. Y., et al. (2001) · Neurology · doi:10.1212/wnl.56.11.1523 · Cited by 233
Burbaud, P., Wiart, L., Dubos, J. L., Gaujard, E., Debelleix, X., Joseph, P. A., Mazaux, J. M., Bioulac, B., Barat, M., & Lagueny, A. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.3.265 · Cited by 232
Byrnes, M. (1998) · Brain · doi:10.1093/brain/121.5.977 · Cited by 231
Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial
Marras, C., Andrews, D., Sime, E., & Lang, A. E. (2001) · Neurology · doi:10.1212/wnl.56.5.605 · Cited by 212
Botulinum toxin A for spasticity, muscle spasms, and rigidity
Grazko, M. A., Polo, K. B., & Jabbari, B. (1995) · Neurology · doi:10.1212/wnl.45.4.712 · Cited by 207
Hsiung, G. R., Das, S. K., Ranawaya, R., Lafontaine, A. ‐., & Suchowersky, O. (2002) · Movement Disorders · doi:10.1002/mds.10252 · Cited by 204
Giess, R. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.121 · Cited by 199
Botulinum Toxin in the Treatment of Tics
Kwak, C. H., Hanna, P. A., & Jankovic, J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.8.1190 · Cited by 187
Self-citationNaumann, M. K., Hamm, H., Lowe, N. J., & ON BEHALF OF THE BOTOXR HYPERHIDROSIS CLINICAL STUDY GROUP (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.05059.x · Cited by 177
Baker, R., Jasinski, M., Maciag-Tymecka, I., Michalowska-Mrozek, J., Bonikowski, M., Carr, L., MacLean, J., Lin, J.-P., Lynch, B., Theologis, T., et al. (2002) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162201002730 · Cited by 168
Warrick, P., Dromey, C., Irish, J. C., Durkin, L. C., Pakiam, A. S.-I., & Lang, A. E. (2000) · The Laryngoscope · doi:10.1097/00005537-200008000-00028 · Cited by 137
Not paralysis, but dystonia causes stridor in multiple system atrophy
Merlo, I. M., Occhini, A., Pacchetti, C., & Alfonsi, E. (2002) · Neurology · doi:10.1212/wnl.58.4.649 · Cited by 130
Schmitt, W. J., Slowey, E., Fravi, N. L., Weber, S., & Burgunder, J. (2001) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007658.x · Cited by 128
Treatment of dystonic clenched fist with botulinum toxin
Cordivari, C., Misra, V. P., Catania, S., & Lees, A. J. (2001) · Movement Disorders · doi:10.1002/mds.1186 · Cited by 127
Perisphincteric Injection of Botulinum Toxin Type A
Zermann, D.-H., Ishigooka, M., Schubert, J., & Schmidt, R. A. (2000) · European Urology · doi:10.1159/000020314 · Cited by 113
Botulinum Toxin for Cricopharyngeal Dysfunction in Parkinson's Disease
Restivo, D. A., Palmeri, A., & Marchese‐Ragona, R. (2002) · New England Journal of Medicine · doi:10.1056/nejm200204113461517 · Cited by 109
Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor
Wissel, J., Masuhr, F., Schelosky, L. D., Ebersbach, G., & Poewe, W. H. (1997) · Movement Disorders · doi:10.1002/mds.870120516 · Cited by 109
Writer's cramp: Treatment with botulinum toxin injections
Rivest, J., Lees, A. J., & MARSDEN, C. D. (1991) · Movement Disorders · doi:10.1002/mds.870060110 · Cited by 92
Molecular mechanisms of neurotransmitter release
Fon, E. A., & Edwards, R. H. (2001) · Muscle & Nerve · doi:10.1002/mus.1044 · Cited by 89
Severe constipation in parkinson's disease relieved by botulinum toxin
Albanese, A., Maria, G., Bentivoglio, A. R., Brisinda, G., Cassetta, E., & Tonali, P. A. (1997) · Movement Disorders · doi:10.1002/mds.870120524 · Cited by 76
Outcomes Assessment following Treatment of Spasmodic Dysphonia with Botulinum Toxin
Courey, M. S., Garrett, C. G., Portell, M. D., Billante, C. R., Smith, T. L., Stone, R. E., & Netterville, J. L. (2000) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348940010900906 · Cited by 70
Giladi, N., Gurevich, T., Shabtai, H., et al. (2001) · Journal of Neurology · doi:10.1007/s004150170134 · Cited by 68
Perioperative use of botulinum toxin for movement disorder–induced cervical spine disease
Adler, C. H., Zimmerman, R. S., Lyons, M., Simeone, F. A., & Brin, M. F. (1996) · Movement Disorders · doi:10.1002/mds.870110114 · Cited by 63
Laryngeal botulinum toxin injections for disabling stuttering in adults
Brin, M. F., Stewart, C. F., Blitzer, A., & Diamond, B. E. (1994) · Neurology · doi:10.1212/wnl.44.12.2262 · Cited by 61
Effect of dystonia and botulinum toxin treatment on health‐related quality of life
Gudex, C. M., Hawthorne, M. R., Butler, A. G., & Duffey, P. (1998) · Movement Disorders · doi:10.1002/mds.870130613 · Cited by 59
Botulinum Toxin therapy for myofascial pain disorders
Lang, A. M. (2002) · Current pain and headache reports · doi:10.1007/s11916-002-0076-8 · Cited by 53
Cho, J., Chu, K., & Jeon, B. S. (2001) · Movement Disorders · doi:10.1002/mds.1132 · Cited by 33
Cited by
Jankovic, J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70574-9 · Cited by 332
Self-citationTreatment of hyperkinetic movement disorders
Jankovic, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70183-8 · Cited by 252
Self-citationThermoregulatory and thermal control in the human cutaneous circulation
Kellogg, D. L. (2010) · Frontiers in Bioscience · doi:10.2741/s105 · Cited by 137
Metadata
- Authors
- Jankovic, J.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2004-07-01
- Volume
- 75
- Issue
- 7
- Pages
- 951-957
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2129974957
- Cited by
- 408
- References
- 46
- FWCI
- 17.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.